Investigation of genotoxicity in acromegaly from peripheral blood lymphocyte cultures using a micronucleus assay

J Clin Endocrinol Metab. 2014 Oct;99(10):E2060-6. doi: 10.1210/jc.2014-1641. Epub 2014 Jun 25.

Abstract

Context: Although patients with acromegaly may have an increased risk of developing several types of cancers, the degree of risk for malignancy in these patients is unresolved.

Objective: The present study aimed to investigate the potential genotoxic effects of acromegaly on the cell cycle in peripheral blood lymphocyte cultures.

Design: This was a single center, crossover, case-control study conducted on the acromegalic patients in Turkey.

Setting: The study was conducted in the outpatient clinic of a university hospital.

Patients: Seventy-one consecutively screened acromegalic patients and 56 controls participated in the study.

Intervention: Patients were included, regardless of the disease activity status and their treatment duration before the study.

Main outcome measures: The primary end point was the frequency of micronucleus (MN) in the peripheral blood lymphocyte cultures, and the secondary end point was its clinical correlations.

Results: The MN level was 3.82 ± 1.49 in the control group and 18.00 ± 6.13 in the acromegalic group (P < .01), whereas the nuclear division index (NDI) was 1.79 ± 0.12 in the control group and 1.68 ± 0.07 in the acromegalic group (P < .01). Neither MN nor NDI was correlated with age, GH, IGF-I, initial GH, initial IGF-I, duration of the remission period, and initial tumor size. Only the MN level was positively correlated with the duration of disease (r = 0.323, P = .014).

Conclusion: Our results indicated that acromegalic patients had genotoxic damage at a substantial level, and there was a positive correlation between the duration of disease and genotoxicity level.

MeSH terms

  • Acromegaly / epidemiology*
  • Acromegaly / genetics*
  • Adult
  • Case-Control Studies
  • Cells, Cultured
  • Cross-Over Studies
  • Female
  • Human Growth Hormone / genetics
  • Humans
  • Insulin-Like Growth Factor I / genetics
  • Lymphocytes / cytology
  • Lymphocytes / physiology
  • Male
  • Micronucleus Tests / methods
  • Middle Aged
  • Mutagenicity Tests
  • Neoplasms / epidemiology*
  • Neoplasms / genetics*
  • Risk Factors
  • Turkey / epidemiology

Substances

  • Human Growth Hormone
  • Insulin-Like Growth Factor I